STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

March 26, 2025

Period of Report

March 24, 2025

Accession Number

0001062993-25-006335